药物对比
Canagliflozin vs Insulin Degludec
Canagliflozin（Invokana）与Insulin Degludec（Tresiba）：口服SGLT2抑制剂与长效胰岛素。比较两者在2型糖尿病中的用途、疗效及副作用。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients not at goal on orals who are considering an SGLT2 inhibitor versus starting basal insulin.
结论
Canagliflozin is often preferable for oral convenience and added benefits in type 2 diabetes, whereas Insulin Degludec is essential when insulin replacement is required.
全部药物对比